November 3, 2017

NEW to the United States: Equelle®, a Non-Hormonal Supplement Clinically Shown to Help Ease Menopause Symptoms*

NEW to the United States: Equelle®, a Non-Hormonal Supplement Clinically Shown to Help Ease Menopause Symptoms*


Available exclusively to integrative healthcare professionals as an alternative therapy for menopausal women

Manchester, NH (November 3, 2017) – INNATE Response, manufacturer of naturally-inspired supplements that support and strengthen the body’s innate healing response, announced the United States launch of Equelle, a non-hormonal dietary supplement clinically shown to help ease the symptoms commonly experienced during menopause, such as hot flashes and muscle discomfort.* The supplement will be available to integrative healthcare professionals exclusively through Emerson Ecologics® beginning October 30, 2017.

“Menopause is a normal, transitionary period of life that all women will eventually experience,” said Tieraona Low Dog, M.D., an integrative medical doctor and expert in integrative medicine, women’s health, herbal medicine and dietary supplements. “In the United States alone, there are 53 million women between the menopause ages of 40 to 64, and increasingly, these women want and use complementary therapies to manage symptoms of menopause. I’m delighted that clinicians now have the opportunity to recommend Equelle as a part of a total approach in the management of menopause.”

The active ingredient in Equelle is S-equol, a metabolite of the soy isoflavone daidzein, which can be naturally produced in the intestinal tract. Clinical studies have shown that incorporating the regular use of an S-equol supplement like Equelle can ease menopausal symptoms in as few as four weeks, with optimal results shown after 8 to 12 weeks of consistent use.* Since only 20 to 30 percent of women in the U.S. have the ability to naturally produce S-equol in their bodies, those seeking to benefit from S-equol to manage menopausal symptoms may find supplementation essential.

Equelle is the product of fermentation of whole, non-GMO soy germ using a patented and proprietary process by the Otsuka Pharmaceutical Co., Ltd. The process results in the conversion of the daidzein to S-equol. Equelle tablets, created under current Good Manufacturing Practices, are clear coated and free of gluten, dairy, magnesium stearate and talc. Suggested patient use is two Equelle tablets daily, one tablet taken in the morning and one tablet at night, which provide the standardized dose of 10 mg of S-equol.

Clinicians interested in ordering Equelle may do so via, or by calling Emerson Ecologics directly at 800.654.4432. In addition, INNATE Response’s customer support team is available at 800.634.6342 or [email protected] for questions and assistance with product ordering. Interested patients should ask their healthcare practitioner about how Equelle can help with their menopause symptoms. To learn more about Equelle, visit

©FoodState, Inc. 2017.

About INNATE Response

At INNATE Response, we share the belief that nothing is more important than restoring the body’s innate ability to heal. To that end, we develop nutrient-rich supplements that embrace the wholism of nature and help people achieve optimal health.* We are committed to supporting wholistic healthcare professionals who understand that the body always seeks wellness, and who appreciate the wisdom of nature in their protocols. For more information, please visit and

About Otsuka Pharmaceutical Co., Ltd.

Otsuka researches, develops, manufactures and markets innovative products, with a focus on pharmaceutical products for the treatment of diseases and nutraceutical products for the maintenance of everyday health.

Otsuka Pharmaceutical is a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan. The Otsuka group of companies employed 45,000 people worldwide and had consolidated sales of approximately USD 11 billion in 2016.

Otsuka Pharmaceutical welcomes you to visit its global website at

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Media Contact:

Curt Finckler, INNATE Response

[email protected] / 617-304-3988


Categorized Under